| Clonal replacement of tumor-specific T cells following PD-1 blockade KE Yost*, AT Satpathy*, DK Wells, Y Qi, C Wang, R Kageyama, ... Nature medicine 25 (8), 1251-1259, 2019 | 1197 | 2019 |
| Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion AT Satpathy*, JM Granja*, KE Yost, Y Qi, F Meschi, GP McDermott, ... Nature biotechnology 37 (8), 925-936, 2019 | 745 | 2019 |
| Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element SW Cho*, J Xu*, R Sun, MR Mumbach, AC Carter, YG Chen, KE Yost, ... Cell 173 (6), 1398-1412. e22, 2018 | 434 | 2018 |
| Single-cell analyses identify brain mural cells expressing CD19 as potential off-tumor targets for CAR-T immunotherapies KR Parker*, D Migliorini*, E Perkey, KE Yost, A Bhaduri, P Bagga, M Haris, ... Cell 183 (1), 126-142. e17, 2020 | 367 | 2020 |
| Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen SA Vardhana, MA Hwee, M Berisa, DK Wells, KE Yost, B King, M Smith, ... Nature immunology 21 (9), 1022-1033, 2020 | 315 | 2020 |
| Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2 SCA Nielsen*, F Yang*, KJL Jackson*, RA Hoh*, K Röltgen, GH Jean, ... Cell host & microbe 28 (4), 516-525. e5, 2020 | 244 | 2020 |
| ecDNA hubs drive cooperative intermolecular oncogene expression KL Hung*, KE Yost*, L Xie*, Q Shi, K Helmsauer, J Luebeck, R Schöpflin, ... Nature 600 (7890), 731-736, 2021 | 184 | 2021 |
| Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence JA Belk, W Yao, N Ly, KA Freitas, YT Chen, Q Shi, AM Valencia, E Shifrut, ... Cancer cell 40 (7), 768-786. e7, 2022 | 168 | 2022 |
| Integrated spatial multiomics reveals fibroblast fate during tissue repair DS Foster*, M Januszyk*, KE Yost, MS Chinta, GS Gulati, AT Nguyen, ... Proceedings of the National Academy of Sciences 118 (41), e2110025118, 2021 | 115 | 2021 |
| Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study ALS Chang, DC Tran, JGD Cannon, S Li, M Jeng, R Patel, ... Journal of the American Academy of Dermatology 80 (2), 564-566, 2019 | 105 | 2019 |
| Reinfection with SARS-CoV-2 and waning humoral immunity: a case report JD Goldman, K Wang, K Röltgen, SCA Nielsen, JC Roach, SN Naccache, ... Vaccines 11 (1), 5, 2022 | 104* | 2022 |
| BABEL enables cross-modality translation between multiomic profiles at single-cell resolution KE Wu, KE Yost, HY Chang, J Zou Proceedings of the National Academy of Sciences 118 (15), e2023070118, 2021 | 98 | 2021 |
| Divergent clonal differentiation trajectories of T cell exhaustion B Daniel*, KE Yost*, S Hsiung*, K Sandor, Y Xia, Y Qi, KJ Hiam-Galvez, ... Nature Immunology 23 (11), 1614-1627, 2022 | 95 | 2022 |
| The evolutionary dynamics of extrachromosomal DNA in human cancers JT Lange*, JC Rose*, CY Chen*, Y Pichugin*, L Xie, J Tang, KL Hung, ... Nature Genetics 54 (10), 1527-1533, 2022 | 95* | 2022 |
| Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin DS Foster*, M Januszyk*, D Delitto*, KE Yost, M Griffin, J Guo, N Guardino, ... Cancer Cell 40 (11), 1392-1406. e7, 2022 | 91 | 2022 |
| Recruiting T cells in cancer immunotherapy KE Yost, HY Chang, AT Satpathy Science 372 (6538), 130-131, 2021 | 77 | 2021 |
| Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation K Kraft*, KE Yost*, SE Murphy, A Magg, Y Long, MR Corces, JM Granja, ... Proceedings of the National Academy of Sciences 119 (22), e2201883119, 2022 | 55 | 2022 |
| TCR-BERT: learning the grammar of T-cell receptors for flexible antigen-binding analyses KE Wu, K Yost, B Daniel, J Belk, Y Xia, T Egawa, A Satpathy, H Chang, ... Machine Learning in Computational Biology, 194-229, 2024 | 45 | 2024 |
| Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation AC Carter*, J Xu*, MY Nakamoto, Y Wei, BJ Zarnegar, Q Shi, ... Elife 9, e54508, 2020 | 44 | 2020 |
| Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells KE Yost*, SF Clatterbuck Soper*, RL Walker, MA Pineda, YJ Zhu, ... Scientific reports 9 (1), 1-11, 2019 | 44 | 2019 |
Howard Y. ChangStanford University在 stanford.edu 的电子邮件经过验证
